Keyphrases
COVID-19
93%
MRNA Vaccine
64%
Hepatitis B Virus
52%
Lymph Node
49%
Germinal Center
47%
Vaccination
47%
Cell Response
44%
Memory B Cells
43%
Germinal Center Reaction
40%
T Follicular Helper Cells
38%
Bone Marrow Plasma Cells
38%
B Cell Response
38%
Immunogenicity
38%
AIDS/HIV
36%
AIDS Clinical Trials
35%
HIV Patients
35%
Germinal Center B Cells
34%
Chronic Inflammatory Diseases
33%
Hepatitis B Virus Genotype
33%
Nevirapine
33%
Influenza Vaccination
33%
Tumor-draining Lymph Nodes
30%
Antiretroviral Therapy
29%
Vaccine Response
28%
CD4+ T
28%
Efavirenz
26%
Hepatitis B e Antigen (HBeAg)
26%
Tfh Cells
25%
Antiretroviral Regimens
24%
North America
23%
Lamivudine
22%
Protease Inhibitors
22%
Somatic Hypermutation
22%
B Cells
21%
Hepatitis B Surface Antigen (HBsAg)
21%
Naïve B Cells
21%
SARS-CoV-2 Vaccination
20%
SARS-CoV-2 mRNA Vaccination
20%
Long-lived
20%
B-cell Clone
20%
Stavudine
19%
Antiretroviral
19%
SARS-CoV-2 Spike Protein
19%
Monoclonal Antibody
19%
Chronic Hepatitis B Virus
19%
Longitudinal Cohort
19%
Human Immunodeficiency Virus Type 1 (HIV-1)
18%
Chronic Hepatitis B Virus Infection
18%
Clinical Outcomes
18%
Immunosuppression
17%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Spike
77%
Germinal Center
64%
Lymph Node
61%
B Cell
58%
Immunogenicity
42%
Follicular B Helper T Cells
37%
Maturation
35%
Inflammatory Disorder
33%
Hepatitis B Virus
33%
Influenza
33%
Memory B Cell
32%
T-Helper Cell
25%
Immunoglobulin Producing Cell
21%
Human Immunodeficiency Virus
21%
CD4
19%
Naive B Cell
19%
Promoter Region
16%
Immunosuppression
16%
Omicron Coronavirus Variant
16%
Allele
16%
T Cell Receptor
16%
HBsAg
16%
Hepatitis B Antigen
16%
Viral Load
16%
Hepatitis B(e) Antigen
16%
Monoclonal Antibody
14%
Somatic Hypermutation
13%
Blood Plasma
12%
Plasmablast
10%
Epitope
10%
Cell Clone
9%
COVID-19
9%
Titer
9%
Axillary Lymph Node
8%
Antibody Titer
8%
Hepatitis B
7%
Antigen Specificity
7%
Influenza Virus
6%
Immunoglobulin G Antibody
5%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
50%
Human Immunodeficiency Virus
40%
Infection
35%
Chronic Hepatitis B
33%
Germinal Center
25%
Hepatitis B Virus
23%
B Cell
21%
Efavirenz
21%
Antiretroviral Therapy
19%
Immunoglobulin Producing Cell
19%
Omicron Coronavirus Variant
16%
Cross Sectional Study
16%
Sporotrichosis
16%
Antiviral Therapy
16%
Adverse Outcome
16%
Liver Cirrhosis
16%
COVID-19 Vaccination
16%
Lymph Node
16%
Patient-Reported Outcome
16%
Human Immunodeficiency Virus Infection
16%
Proteinase Inhibitor
16%
Nevirapine
16%
Quality of Life
14%
Hepatitis B
14%
Hepatitis B(e) Antigen
13%
mRNA Vaccine
12%
Comorbidity
11%
Reinfection
10%
COVID-19
8%
Insulin Tolerance Test
8%
Checklist
8%
Itraconazole
8%
Memory B Cell
6%
Epitope
6%
Hepatitis B Antigen
6%
Platelet
5%
Virus Infection
5%
Liver Disease
5%
